Skip to main content

Table 3 Descriptive statistics of included studies

From: Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA)

Article

Year

Country

Type of HTA

Methodology

Baeten [25]

2010

International (Netherlands, US, UK)

Mainstream

DCE

Baltussen [26]

2005

Ghana

Mainstream

DCE

Baltussen [27]

2007

Nepal

Mainstream

DCE

Bots [34]

1995

The Netherlands

Very early

SMART (simple attribute rating technique)

Cho [29]

2000

Korea

Very early

AHP

Diaby [35]

2011

Ivory Coast

Mainstream

DCE

Goetghebeur [36]

2012

Canada

Mainstream

Direct weighting, on 5-point scale

Goetghebeur [37]

2010

Canada

Mainstream

Direct weighting, on 5-point scale

Golan [43]

2012

Israel

Mainstream

PAPRIKA (Potentially All Pairwise RanKing of all possible Alternatives)

Hilgerink [30]

2011

The Netherlands

Early

AHP

Hummel [31]

2012

The Netherlands

Early

AHP

Jehu- Appiah [28]

2008

Ghana

Mainstream

DCE

Le Gale [38]

1990

France

Mainstream

Direct weighing and outranking (ELECTRE 1S Model)

Miot [39]

2011

South Africa

Mainstream

Direct weighting, on 5-point scale

Marsh [44]

2012

UK

Mainstream

DCE

Shin [32]

2008

South Korea

Mainstream

AHP

Sloane [33]

2003

US

Mainstream

AHP

Tony [40]

2010

Canada

Mainstream

Direct weighting, on 5-point scale

Venhorst [46]

2014

Netherlands

Mainstream

Direct weighting

Wilson [41]

2006

UK

Mainstream

Weighted benefit score (WBS)

Youngkong [42]

2011

Thailand

Mainstream

DCE with deliberation process

Youngkong [45]

2012

Thailand

Mainstream

Direct weighting with consideration of DCE results